Current Drug Therapy
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 1
Author(s): Stefano Angioni*
Affiliation:
- Department of Surgical Sciences University of Cagliari, Cagliari,Italy
Export Options
About this article
Cite this article as:
Angioni Stefano*, Meet Our Editorial Board Member, Current Drug Therapy 2017; 12 (1) . https://dx.doi.org/10.2174/157488551201170502190936
DOI https://dx.doi.org/10.2174/157488551201170502190936 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides
Current Radiopharmaceuticals Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1
Anti-Cancer Agents in Medicinal Chemistry Recent Advance in the Research of Flavonoids as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Tumor Targeted Therapies: Strategies for Killing Cancer but not Normal Cells
Current Cancer Therapy Reviews Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Strategies for Increasing the Solubility and Bioavailability of Anticancer Compounds: β-Lapachone and Other Naphthoquinones
Current Pharmaceutical Design Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data
Current Bioactive Compounds Chemical Biology: Past, Present and Future
Current Chemical Biology Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption
Recent Patents on Anti-Cancer Drug Discovery Advances in Drug Safety
Current Pharmaceutical Design The Tribbles-1 Protein in Humans: Roles and Functions in Health and Disease
Current Molecular Medicine Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Current Drug Metabolism Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
Current Medicinal Chemistry Insights in microRNAs Biology
Current Topics in Medicinal Chemistry mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery MicroRNAs as Therapeutic Targets for Anticancer Drugs in Lung Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry